Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ascletis Announces IND Approval of Oral 3CLpro Inhibitor ASC11 for COVID-19 by China NMPA
Ascletis Pharma has announced that China National Medical Products Administration (NMPA) has approved the Investigational […]
Touchlight and Odimma Therapeutics Announce Clinical Material Supply Agreement to Develop Personalised Cancer Therapy Utilising Doggybone DNA
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has announced a […]
BASF Pharma Solutions Excipient Accepted into FDA Pilot Program for Novel Excipients
BASF Pharma Solutions announces that the US Food and Drug Administration (FDA) Center for Drug […]
Enthea Announces Nationwide Rollout to Offer Psychedelic Therapy as a Workplace Benefit
Enthea, the first provider of insurance plans for psychedelic healthcare, announces its successful $2M seed […]
Medikine Appoints Roland Buelow, Ph.D., to Board of Directors
Medikine, a clinical-stage biopharmaceutical company developing transformative therapeutics for cancer, autoimmune disorders, and infectious diseases […]
Daewoong Pharmaceutical Announces Success in Developing a New Antidiabetic Medication
Daewoong Pharmaceutical, a global healthcare company, has announced that its “Envlo 0.3mg“, a new sodium-glucose […]
PacBio and Boston Children's Hospital Collaborate to Investigate Novel Variants Inaccessible by Short-Read Sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, has announced its HiFi sequencing […]
AbbVie Launches Strategic Collaboration with HotSpot Therapeutics to Further Expand Immunology Pipeline
AbbVie and HotSpot Therapeutics, a biotechnology company pioneering the discovery and development of small molecule […]
Caris Life Sciences and Hummingbird Bioscience Enter Into Collaboration to Advance Clinical Development of Anti-HER3 Therapy
Caris Life Sciences®, the leading molecular science and technology company actively developing and delivering innovative […]
Reliq Health Technologies Announces 35 New Skilled Nursing Facilities Clients in Florida
Reliq Health Technologies, a rapidly growing global healthcare technology company that develops innovative Virtual Care […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more